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Internet
iCBTInternet-delivered cognitive behavior therapy (iCBT) may reduce barriers to treatment faced by people with ob-
sessive–compulsive disorder (OCD). To date,most research on iCBT for OCD has evaluated clinician-guided treat-
ments. However, self-guided treatments, which do not involve contact with a clinician, have considerable public
health potential andmay be particularly advantageous for those patients who report stigma as a principal barrier
to treatment. The ﬁndings of a recent trial of self-guided iCBT for symptoms of OCD highlighted the potential of
this approach and found largewithin-group effect sizes frompre- to post-treatment on the YBOCS-SR (d=1.37),
sustained at 3-month follow-up (d= 1.17). In addition, 32% of participants met criteria for clinically signiﬁcant
change at 3-month follow-up. The present study reports the long-term outcomes of that trial (N= 28). Twelve
out of 28participants (43%) completed the 12month follow-up. A largewithin-group effect sizewas found on the
YBOCS-SR (d=1.08) and 33%met criteria for clinically signiﬁcant change at 12-month follow-up. No signiﬁcant
changes in symptoms were found between 3-month follow-up and 12-month follow-up, demonstrating that
participants maintained their treatment gains in the long term. These results add to the emerging literature
supporting the potential of self-guided iCBT for individuals with symptoms of OCD.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obsessive–compulsive disorder (OCD) is characterized by intrusive
obsessions and related, anxiety reducing compulsions (APA, 2013). Ef-
fective cognitive-behavioral treatments for OCD exist and are well doc-
umented in the literature (Olatunji et al., 2013; Sánchez-Meca et al.,
2014). However, there are numerous barriers to accessing traditional
face-to-face treatments, including the direct and indirect costs of treat-
ment, stigma, and difﬁculty accessing a trained therapist (Baer and
Minichiello, 2008; Belloch et al., 2009; Goodwin et al., 2002; Marques
et al., 2010). Internet-delivered cognitive behavioral therapy (iCBT)
has increasingly been studied in recent years as a potential way to over-
come many of these barriers.
Internet-delivered cognitive behavioral therapy involves the same
evidence-based treatment techniques that are delivered in traditional
face to face treatments; however, the treatment information is provided
online (Andersson and Titov, 2014). Internet-delivered cognitive behav-
ioral therapy can be clinician-guided (i.e., with clinician contact provid-
ed via telephone or email) or self-guided (i.e., without any clinician
contact). To date, the majority of the studies examining iCBT for OCDology), University of Tasmania,
ootton).
. This is an open access article underhave examined guided interventions, involving at least weekly clinician
contact (Andersson et al., 2011, 2012; Lenhard et al., 2014; Wootton
et al., 2011, 2013), or contact with a technician (Mahoney et al., 2014).
Several studies now support the efﬁcacy of clinician-guided iCBT for
OCD with effect sizes, across three different research groups, ranging
from 0.87 to 2.29 on relevant OCD outcome measures (Andersson
et al., 2011, 2012; Lenhard et al., 2014; Mahoney et al., 2014; Wootton
et al., 2011, 2013). While the results of these studies are encouraging,
self-guided interventions have an important advantage over guided
treatments including that they may be more attractive to patients who
have signiﬁcant concerns regarding stigma than guided treatments.
One recent study reported the results of two open trials exploring
the efﬁcacy of a new iCBT intervention for OCD, the OCD Course, when
provided in a self-guided format (Wootton et al., 2014). Entry to both
studies required a score of ≥16 on the self-report Yale–BrownObsessive
Compulsive Scale (YBOCS-SR) (Baer, 1991) and no clinician contact or
support was provided to participants during assessment or treatment.
In the ﬁrst open trial (N= 20), 44% of participants completed the OCD
Coursewithin 8weeks and signiﬁcant improvements in OCD symptoms
were observed from pre-treatment to post-treatment (d=1.05) and to
3-month follow-up (d=1.34) (Wootton et al., 2014). In the second trial
(N=28), the time allowed to complete the intervention was increased
(i.e., from 8weeks to 10 weeks) to allowmore practice of exposure and
response prevention (ERP) tasks. Sixty-four percent of participantsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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signiﬁcant reductions in symptoms of OCD were also found with large
effect sizes obtained at post-treatment (d = 1.37) and 3-month
follow-up (d= 1.17) (Wootton et al., 2014). Importantly, participants
in these open trials reported the iCBT Course to be acceptable. At post-
treatment 80% of participants in the ﬁrst trial indicated that it was
worth their time taking part in the Course, which increased to 100% in
the second trial. In addition, 80% of participants in the ﬁrst open trial in-
dicated that they would recommend the Course to a friend and this per-
centage increased to 100% in the second trial.
Currently, one of the limitations of the self-guided iCBT literature is
the lack of long-term follow-up data. Recently, Andersson and col-
leagues reported the long-term outcomes for a randomized controlled
trial (RCT) of clinician-guided iCBT for OCD (Andersson et al., 2014).
Participants in this RCT were randomized, at post-treatment, to either
receive no additional contact after treatment or to receive an internet-
delivered booster program, and were followed up at 4-, 7-, 12- and
24-months post-treatment (Andersson et al., 2014). Results from this
study indicated that both groups maintained their treatment gains
with within-group effect sizes ranging from 1.58 to 2.09 across the
follow-up time period (Andersson et al., 2014). Thus, there is emerging
evidence to suggest that the clinical outcomes of clinician-guided iCBT
for OCD are maintained over the longer term.
The aim of the present study was to extend the existing literature by
reporting the long-term follow-up of self-guided iCBT for OCD. It was
hypothesized, based on recent ﬁndings in the literature, that partici-
pants would maintain treatment gains at 12-months post-treatment.
2. Method
2.1. Participants
The original trial comprised a single-group feasibility open
trial involving 28 participants who commenced a modiﬁed versionFig. 1. Participant ﬂow. PHQ-9: Patient Health Questionnaire, 9-item; YBOCS-SR, Yale–Brown O
participants were excluded if they scored above a total score N22 or response N2 on Questionof the OCD Course (Wootton et al., 2014). Participants applied
online and completed self-report measures of OCD symptoms
at pre-treatment, post-treatment and 3-month follow-up. The
speciﬁc inclusion and exclusion criteria and short term outcomes
are detailed in the original report (Wootton et al., 2014). Appli-
cants were required to score ≥16 on the YBOCS-SR at application
in order to participate and the researchers had no clinical contact
with participants via telephone or email during the trial
(Wootton et al., 2014). The 28 participants were followed up 12-
months after the completion of the iCBT Course and this data is re-
ported in the current study. Participant ﬂow can be seen in Fig. 1
and the characteristics of the sample can be seen in Table 1.
The study was approved by the Human Research Ethics
Committee of Macquarie University and was registered with
the Australian and New Zealand Clinical Trials Register
(ACTRN12612000954820).2.2. Outcome measures
Participants were administered the following self-report out-
come measures: 1) The Yale Brown Obsessive Compulsive Scale —
Self-Report Version (YBOCS-SR) (Baer, 1991), a 10-item question-
naire that measures the severity of OCD symptoms independently
of the symptom subtype. Cronbach's alpha (α) was .73 in the current
study. 2) The Dimensional Obsessive Compulsive Scale (DOCS)
(Abramowitz et al., 2010), a 20-item scale that measures four empir-
ically validated dimensions of OCD (i.e., contamination, responsibil-
ity for harm, ordering, and unacceptable thoughts). The internal
reliability for the total score of this measure (α) in the current
study was .86. 3) The Patient Health Questionnaire (9 item) (PHQ-
9) (Kroenke et al., 2001), a widely used 9-item questionnaire mea-
suring symptoms of depression. Total scores range from 0 to 27,
and α in the current study was .83.bsessive Compulsive Scale— Self Report. Being a self-guided treatment focussed on OCD,
9 (suicidal ideation) of the PHQ-9.
Table 1
Demographic characteristics of the sample at pre-treatment (N= 28).
Variable N %
Gender
Male 9 32.1
Female 19 67.9
Age
Mean (SD) 35.90 (11.23) –
Range 19–62 –
Marital status
Single/never married 14 50.0
Married/de-facto 12 42.9
Separated/divorced/widowed 2 7.1
Education
High school 4 14.3
Technical certiﬁcate 8 28.6
Tertiary 16 57.1
Employment
Employed 16 57.1
Unemployed 12 42.9
Previous treatment (% yes)a 22 78.6
Psychotropic medication (% yes) 9 32.1
YBOCS-SR severity
Mild 3 10.7
Moderate 19 67.9
Severe 5 17.9
Extreme 1 3.6
DOCS dominant subtypeb
Contamination/washing 7 25.0
Harming/checking 7 25.0
Ordering/arranging 9 32.1
Thoughts/mental rituals 11 39.3
Note. Standard deviations are indicated in parentheses. YBOCS-SR: Self-Report Yale Brown
Obsessive Compulsive Scale. DOCS: Dimensional Obsessive-Compulsive Scale.
a Speciﬁc detail on the type of previous treatment obtained is unavailable.
b Percentages on the DOCS do not add to 100% as some participants indicated multiple
dominant symptom domains.
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The treatment protocol is a 6-lesson iCBT program, the OCD Course,
which is provided over 10weeks. Each lesson is released serially accord-
ing to a timeline and participants can only access later lessons after
completing earlier lessons. Lesson 1 (released week 1) provides
psycho-education, Lesson 2 (released week 2) provides information
on cognitive distortions in OCD, Lesson 3 (released week 4) includes in-
formation on physical symptoms of anxiety and depression, Lessons 4
(released week 5) and 5 (released week 7) include information and in-
struction on exposure and response prevention and Lesson 6 (released
week 8) provides information about relapse prevention. Each lesson in-
cludes assigned homework tasks, and participants are instructed to
practice their homework tasks for at least 1 h per day. During treatment
participants also receive regular automated emails notifying them of
new course materials and reminding them when they have not com-
pleted a lesson. No clinician contact was provided during the treatment
or follow-up period.2.4. Data analysis
Changes over time were analyzed using mixed linear model (MLM)
analyses using an autocorrelated covariance structure. Effect sizes
(Cohen's d) and 95% conﬁdence intervals were calculated for within-
group changes, based on the pooled standard deviation for the entire
sample (i.e., using the estimated marginal means from the MLM) and
completer sample (i.e., those who completed the 12-month follow-up
questionnaires). Reliable change (improvement or deterioration) was
measured using the reliable change index (RCI) (Jacobson and Truax,
1991) criteria (a reduction or increase of at least 5 points on the
YBOCS-SR). Clinically signiﬁcant change was deﬁned as a score 2SD
below the pre-treatment mean on the YBOCS-SR (a score of ≤11 inthis case) in addition tomeeting the reliable change index (RCI) criteria.
In these analyses, the last available scores were carried forward for any-
one who did not complete the 12-month follow-up questionnaires
(i.e., last observation carried forward; LOCF).
3. Results
Twelve-month follow-up data was obtained from 12/28 (43%) par-
ticipants. The immediate (pre-treatment to post-treatment) and
short-term follow-up (pre-treatment to 3-month follow-up) results
are described elsewhere (Wootton et al., 2014). Means, standard devia-
tions and effect sizes (with 95% conﬁdence intervals) for the primary
and secondary outcome measures are shown in Table 2.
A statistically signiﬁcant effect for time was found for the YBOCS-SR
(F(12,154) = 2.27, p = .01) indicating that participant symptoms de-
creased from pre-treatment to 12-month follow-up. There was no sig-
niﬁcant difference between participant symptom scores at 3-month
follow-up and 12-month follow-up (p = .29) indicating that partici-
pants had maintained their treatment gains at the 12-month follow-
up. Similarly, for the secondary outcome measures there was a signiﬁ-
cant effect for time on the DOCSMain subscale (the participant's prima-
ry symptom domain) (F(4,62) = 6.27, p b .001), as well as the
contamination subscale (F(4,64)= 2.87, p= .03), and responsibility sub-
scale (F(4,62) = 3.75, p b .001). There was no signiﬁcant difference in
DOCS Main, contamination, or responsibility subscale scores between
3-month follow-up and 12-month follow-up (p N .05). There was no
signiﬁcant effect for time effect for any the other DOCS subscales,
DOCS total scores or the PHQ-9 at 12-month follow-up (p N .05).
Nine of the 28 participants (32%) met criteria for reliable improve-
ment at 12-month follow-up and 1/28 (4%) met criteria for reliable de-
terioration when using the LOCF. Four of the 12 (33%) participants met
criteria for clinically signiﬁcant change at 12-month follow-up (com-
pleter sample), and 7/28 (25%) participants met criteria at 12-month
follow-up when using the LOCF.
4. Discussion
The aimof this studywas to investigate the long term efﬁcacy of self-
guided iCBT for symptoms of OCD. Twelve of the original 28 participants
(43%) completed the 12-month follow-up measures, and as a result of
the high rate of attrition results should be interpreted as preliminary.
It was hypothesized that clinical outcomes would be maintained at
12-month follow-up, and using both completer and mixed model anal-
yses, this hypothesis was supported, with a signiﬁcant reduction in
scores from pre-treatment to 12-month follow-up, and no signiﬁcant
change from 3-month follow-up to 12-month follow-up. The effect
size on the primary outcome measure (YBOCS-SR) was large for the
completer sample (i.e., d= 1.08) and moderate for the intent-to-treat
sample (i.e., d = 0.63). Reﬂecting this, 33% of respondents using the
conservative LOCF method met criteria for clinically signiﬁcant change
at 12-month follow-up. The outcomes in the current study are similar
to the only other study to examine the long-term efﬁcacy of clinician-
guided iCBT for OCD (Andersson et al., 2014) and extend on the ﬁndings
of that study by highlighting the outcomes of self-guided iCBT for OCD
which are alsomaintained over the longer-term, albeit with a higher at-
trition rate.
While the ﬁndings of the current study are encouraging, it is impor-
tant to note that there was considerable variability in treatment re-
sponse. For example, some participants achieved the criteria for
reliable change (32% met RCI improvement), others not beneﬁtting at
all (64% did not meet RCI criteria), and one participant (4%) indicated
symptoms that met criteria for reliable deterioration. This is not unique
to self-guided iCBT for OCD but does highlight one of the most impor-
tant issues facing the development and routine use of self-guided iCBT
for OCD, speciﬁcally, understanding who beneﬁts from this approach,
what features of iCBT interventions for OCD are important for optimal
Table 2
Means, standard deviations and effect sizes (Cohen's d) for the outcome measures.
Measure Pre-treatment Post-treatment 3-month follow-up 12-month follow-up Effect size Pre-treatment
to 12-month follow-up
Effect size 3-month to
12- month follow-up
Completer sample
YBOCS-SR 20.79 (4.71) 13.56 (6.07) 14.28 (6.70) 14.83 (7.13) 1.08 (0.34–1.77) −0.08 (−0.81–0.65)
DOCS Main 11.96 (3.77) 7.28 (3.09) 7.86 (4.34) 7.19 (3.43) 1.30 (0.54–2.00) 0.17 (−0.57–0.89)
DOCS Total 26.36 (12.53) 19.65 (11.14) 19.50 (11.71) 19.75 (14.56) 0.50 (−0.19–1.18) −0.02 (−0.75–0.71)
DOCS — Contamination 5.75 (5.60) 4.67 (4.06) 4.06 (3.62) 4.83 (4.00) 0.18 (−0.50–0.85) −0.20 (−0.92–0.54)
DOCS — Responsibility 8.18 (5.54) 5.72 (4.18) 6.50 (5.12) 4.50 (4.60) 0.70 (−0.01–1.38) 0.41 (−0.36–1.11)
DOCS — Thoughts 6.50 (5.95) 4.56 (4.03) 4.67 (4.21) 5.50 (4.83) 0.18 (−0.50–0.85) −0.19 (0.19–0.56)
DOCS — Ordering 5.93 (5.14) 4.94 (4.56) 4.28 (3.79) 4.92 (4.91) 0.20 (−0.48–0.87) −0.15 (0.87–0.59)
PHQ-9 9.64 (5.36) 5.72 (5.06) 7.89 (6.14) 7.91 (6.68) 0.30 (−0.39–0.97) 0.00 (−0.74–0.73)
Estimated marginal means
YBOCS-SR 20.79 (5.89) 14.88 (6.83) 15.45 (6.78) 16.65 (7.15) 0.63 (0.09–1.16) −0.17 (−0.69–0.35)
DOCS Main 11.96 (4.07) 8.44 (4.71) 8.75 (4.71) 8.41 (5.08) 0.77 (0.22–1.30) 0.07 (−0.46–0.59)
DOCS Total 26.36 (12.78) 22.34 (14.55) 20.97 (14.44) 19.71 (15.22) 0.47 (−0.06–1.00) 0.08 (−0.44–0.61)
DOCS — Contamination 5.75 (5.06) 4.67 (5.56) 3.82 (5.54) 3.39 (5.75) 0.44 (−0.10–0.96) 0.08 (−0.45–0.60)
DOCS — Responsibility 8.18 (5.24) 6.54 (5.95) 6.82 (6.00) 4.86 (6.39) 0.57 (0.03–1.09) 0.32 (−0.22–0.84)
DOCS — Thoughts 6.50 (5.75) 5.60 (6.19) 5.75 (6.21) 5.99 (6.40) 0.08 (−0.44–0.61) −0.04 (−0.56–0.49)
DOCS — Ordering 5.93 (4.69) 5.35 (5.06) 4.57 (5.06) 5.45 (5.21) 0.10 (−0.43–0.62) −0.17 (−0.69–0.36)
PHQ-9 9.64 (5.29) 6.00 (6.06) 8.26 (6.01) 9.08 (6.27) 0.10 (−0.43–0.62) −0.13 (−0.66–0.39)
Note. TheN for the completer samplewas pre-treatment (N=28), post-treatment (N=18), 3-month follow-up (N=18) and 12-month follow-up (N=12). YBOCS-SR: Self-Report Yale
Brown Obsessive Compulsive Scale. DOCS: Dimensional Obsessive Compulsive Scale. PHQ-9: Patient Health Questionnaire— 9 item.
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may require support from a health professional and making such help
available. There is currently little empirical understanding about who
responds to iCBT treatment. It is likely that a combination of an
individual's characteristics and speciﬁc treatment components are im-
portant in determining who will beneﬁt from iCBT and these character-
istics and featuresmay differ depending onwhether iCBT is delivered in
a clinician or self-guided format, as well as the circumstances of the in-
dividual. For example, recent studies have found that regular automated
emails delivered during a self-guided iCBT course only enhanced com-
pletion rates and clinical outcomes when participants had comorbid
anxiety and depression (Titov et al., 2013, 2014). In that instance the au-
thors argued that regular automated emails helped to overcome the se-
verity of symptoms, which would otherwise have compromised
engagement with treatment. Future research should focus on under-
standing these issues so that we can appropriately and safely target
self-guided iCBT treatments at those people most likely to respond.
This knowledge is important for the safe and effective dissemination
of self-guided iCBT treatment. This is also an important economic
issue given that the overall cost-effectiveness of treatment for OCD
can be improved by providing the most appropriate intervention
based on the level of need of the patient (Diefenbach and Tolin, 2013).
Despite the promising ﬁndings of this study there are a number of
important limitations. First, is the high attrition rate with only 43% of
participants completing the 12-month follow-up questionnaires.
While attrition in long-term efﬁcacy studies is common, our attrition
is higher than those seen in other long-term efﬁcacy studies of self-
guided iCBT (Titov et al., 2014). The high rate of attrition in the current
study does limit the strength of the conclusions that can be drawn from
the data, andmeans that the results of the present study should be con-
sidered with caution. Second, is the absence of structured clinical inter-
views, which were omitted to avoid clinician contact and examine the
intervention in a truly self-guided format. Third, to minimize burden
on participants, the present study only examined outcomes on primary
symptom measures and did not include other potentially important
measures such as obsessive beliefs or quality of lifemeasures. The inclu-
sion of these, and other similar measures would have added to the cur-
rent ﬁndings. Third, the present study employed a single group open
trial design,whichdoes not control for natural remission. Fourth, in con-
trast to previous studies (e.g., Andersson et al., 2012; Mahoney et al.,
2014; Wootton et al., 2013), the present study did not ﬁnd a signiﬁcant
reduction in symptoms of depression. However, it is important to note
that the overall levels of depressive symptoms were subthreshold fordiagnosis and, thus, depressive symptoms were not a relevant outcome
for many participants. Finally, the study did not assess help-seeking be-
havior after the treatment period ended. Consequently, it is possible
that the long term gains seen in this study could be due to another
type of treatment that the participant obtained after the program
ended. Importantly, a large randomized controlled trial of self-guided
iCBT for OCD is currently underway by the research team and these lim-
itations will be addressed in this more robust design.
While further research is required to investigate the long-term efﬁ-
cacy of self-guided iCBT for OCD the results of the current study provide
preliminary evidence indicating that gains made in an entirely self-
guided iCBT course may be sustained up to 12-months after treatment
with approximately one quarter to one third of individuals meeting a
conservative criteria for treatment recovery. When considering the
low cost associated with self-guided treatments, this study has impor-
tant implications for improving access to treatment for individuals
with OCD, especially thosewho are reluctant to seek help due to stigma.References
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